I wonder why those "major" shareholders who knocked back the takeover offer at 22 cents aren't snapping up shares at the current price of price of 9 and a half cents.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025